CoreAge Rx vs Layla

The verdict

CoreAge Rx edges out Layla on the Mom-Tested Score, 94 to 42 (A vs C). Moms who want a flat, no-teaser price, both molecules available, and a signup you can genuinely finish while the baby sleeps — without a phone-tag scheduling loop.

Layla is still a genuine option — standing monthly rates of $199 for compounded semaglutide and $299 for compounded tirzepatide, each fronted by a $99 first-month promotion that is the number the marketing actually leads with. Read live on 2026-08-21, the plan cards say it plainly — "Starting at $99 / 1st Month (Originally $199 / month)" — so the discount is real and it lasts exactly one month. Two things sit alongside it that a reader should see. Quarterly plans are also offered at $297 and $449 and are labeled per month on the card, which cannot be reconciled against the cheaper monthly plans from the public page alone, so those figures are not asserted here. And the page was running a Cyber Week banner with a fifty-percent-off countdown reading zero hours, zero minutes and zero seconds — in August. Against that, its disclosure is better than most: three operating entities are named, including the prescribing practices Beluga Health, P.A. and Pennsylvania Medical, P.C., and all three came back clean on the FDA's warning-letter list. Weigh the six mom factors below against your own priorities.